Completed PHASE3 INTERVENTIONAL 1-arm NCT02967926

Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy

Digital SpyGlass Cholangioscopy Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy

Sponsor: Boston Scientific Corporation

Conditions Cholangitis, Sclerosing Common Bile Duct Diseases Stone - Biliary

Interventions Endoscopic Retrograde Cholangioscopy by SpyGlass (ERCS)

Updated 5 times since 2017 Last updated: Nov 16, 2016 Started: Dec 31, 2015 Primary completion: Oct 31, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02967926, this PHASE3 trial focuses on Cholangitis, Sclerosing and Common Bile Duct Diseases and remains completed. Sponsored by Boston Scientific Corporation, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston Scientific Corporation
Chulalongkorn University

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.